- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05861973
SMARTer Weight Loss Management (SMARTer)
April 10, 2026 updated by: Bonnie Spring, Florida State University
The SMARTer trial will be a three-arm, randomized controlled non-inferiority trial that compares the optimized, adaptive SMARTer intervention, fixed DPP, and Self-Guided (Control).
The trial will address whether a scalable, stepped-care intervention can stand up to gold-standard DPP by achieving comparable weight loss at a lower cost.
Alongside evaluation of clinical non-inferiority, a comprehensive economic evaluation will inform relative affordability.
Cost information is important to inform treatment policy and change standard of care, but is sorely lacking for behavioral interventions.
The SMARTer intervention reduces costs by initially offering minimal intervention to all and stepping up to offer more costly treatment components only to non-responders who fail to attain the target weight loss.
A rigorous economic evaluation planned and designed alongside the SMARTer trial will provide an accurate, robust head-to-head comparison of costs, cost-effectiveness, and projected lifetime health care costs between the three arms.
Study Overview
Status
Recruiting
Conditions
Detailed Description
The proposed study seeks to test the hypothesis that SMARTer is non-inferior to DPP in its effect on 6-month weight loss.
During the 24-week active intervention phase, participants will be randomized to one of three first-line treatments: 1) the adaptive SMARTer intervention, 2) fixed DPP, or 3) usual care assessment-only (control).
Participants will be assessed at 3-month, 6-month, 9-month, and 12-month timepoints to evaluate overall weight loss, and to explore whether SMARTer is cost-effective compared to DPP or standard care.
Study Type
Interventional
Enrollment (Estimated)
492
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Keri A Gladhill, PhD
- Phone Number: 850-645-5401
- Email: keri.gladhill@med.fsu.edu
Study Locations
-
-
Florida
-
Tallahassee, Florida, United States, 32306
- Recruiting
- Florida State University
-
Principal Investigator:
- Bonnie Spring, PhD
-
Contact:
- Keri A Gladhill, PhD
- Phone Number: 850-645-5401
- Email: keri.gladhill@med.fsu.edu
-
Contact:
- Bonnie Spring, PhD
- Phone Number: 850-644-9720
- Email: bonnie.spring@med.fsu.edu
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Over 18 years old
- BMI of ≥25, weight <396 lbs
- Must own a Smartphone, and be willing to install the SMARTer app
- Not enrolled in a formal weight loss program
Exclusion Criteria:
- Cerebrovascular accident or myocardial infarction within six months of enrollment
- Diabetes treated with insulin
- Pregnancy, lactation or intended pregnancy
- Active suicidal ideation
- Anorexia or bulimia
- Requiring an assistive device for mobility
- Taking weight loss medications, such as GLP-1 agonists
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Adaptive SMARTer intervention (SMARTer)
Smartphone application, diet and activity goals, online lessons, brief remote sessions with a Health Promotionist.
Data from a wifi scale will be monitored.
Individuals losing less than .5 lb per week will be stepped up to also be given meal replacement products.
Will have physical measures taken at baseline, 3 months, 6 months, 9 months, and 12 months.
|
Participants will receive calorie, fat, and physical activity goals, a Smartphone application for self-monitoring their diet, activity and weight, online educational readings, and brief bi-weekly remote health sessions with a Health Promotionist.
They will also be loaned a Fitbit tracking device and a wireless Bluetooth scale for 12 months.
|
|
Experimental: Diabetes Prevention Program (DPP)
Fixed intervention using participant program manual, diet and activity logs, hour long remote sessions with a Health Promotionist.
Will have physical measures taken at baseline, 3 months, 6 months, 9 months, and 12 months.
|
In accordance with the Center for Disease Control curriculum, participants will receive a participant log for tracking physical activity, food intake, and weight, a paper participant guide with worksheets, logs, and psycho-educational materials, and 16 hour long remote sessions with a Health Promotionist.
|
|
Active Comparator: Self-Guided Treatment (Self-Guided)
Provides paper and internet resources tailored to geographic area, educating on leading a healthier lifestyle, including information on wellness and physical activity.
Will have physical measures taken at baseline, 3 months, 6 months, 9 months, and 12 months.
|
Provides paper and internet resources tailored to geographic area, educating on leading a healthier lifestyle, including information on wellness and physical activity.
Will have physical measures taken at baseline, 3 months, 6 months, 9 months, and 12 months.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Weight - percent change
Time Frame: Baseline to 6-months
|
Participant percent change in weight (kg) from baseline to 6-months.
|
Baseline to 6-months
|
|
Weight - difference in kg
Time Frame: Baseline to 6-months
|
Participant change in weight (kg) from baseline to 6-months.
|
Baseline to 6-months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Cost
Time Frame: 12-months
|
Costs of SMARTer versus DPP versus Control implementation.
We will utilize a micro-costing approach to capture all costs associated with the implementation of the treatment arms.
|
12-months
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Weight Maintenance - percent change
Time Frame: Baseline to 12-months
|
Explore whether SMARTer stepped care treatment produces greater weight-loss (percent change) from baseline to 12-months and is noninferior to DPP
|
Baseline to 12-months
|
|
Weight Maintenance - difference in kg
Time Frame: Baseline to 12-months
|
Explore whether SMARTer stepped care treatment produces greater weight-loss (difference in kilograms) from baseline to 12-months and is noninferior to DPP
|
Baseline to 12-months
|
|
Moderating effect of food insecurity on percent weight loss at 6 months
Time Frame: Baseline to 6-months
|
Interaction effect between intervention group (SMARTer vs DPP vs Control) and food insecurity on percent weight loss at 6 months, estimated using a linear regression interaction term (β coefficient).
Food insecurity will be assessed using a validated 2-item screener based on the U.S. Household Food Security Survey Module, consisting of two items: (1) worry that food would run out and (2) food not lasting.
Response options are "Often true," "Sometimes true," and "Never true."
Responses will be scored dichotomously (food insecure vs food secure), with food insecurity defined as ≥1 response of "Often true" or "Sometimes true."
Percent weight loss will be calculated as percent change in body weight from baseline to 6 months.
|
Baseline to 6-months
|
|
Moderating effect of neighborhood deprivation on percent weight loss at 6 months
Time Frame: Baseline to 6-months
|
An interaction effect between intervention group (SMARTer vs DPP vs Control) and neighborhood deprivation on percent weight loss at 6 months will be estimated using a linear regression model with an interaction term (β coefficient).
Neighborhood deprivation will be assessed using a Neighborhood Deprivation Index (NDI) derived from U.S. Census tract-level socioeconomic indicators obtained from the American Community Survey, following methods developed by Diez Roux and colleagues.
The NDI will be expressed as a standardized continuous score (z-score), with higher values indicating greater neighborhood deprivation.
Percent weight loss will be calculated as percent change in body weight from baseline to 6 months.
|
Baseline to 6-months
|
|
Moderating effect of technology literacy on percent weight loss at 6 months
Time Frame: Baseline to 6-months
|
Interaction effect between intervention group (SMARTer vs DPP vs Control) and technology literacy on percent weight loss at 6 months, estimated using a linear regression interaction term (β coefficient).
Technology literacy will be assessed using the eHealth Literacy Scale (eHEALS; 8-item measure) total score (range: 8-40), with higher scores indicating greater perceived eHealth literacy.
Percent weight loss will be calculated as percent change in body weight from baseline to 6 months.
|
Baseline to 6-months
|
|
Moderating effect of executive functioning on percent weight loss at 6 months
Time Frame: Baseline to 6-months
|
Interaction effect between intervention group (SMARTer vs DPP vs Control) and executive functioning on percent weight loss at 6 months, estimated using a linear regression interaction term (β coefficient).
Executive functioning will be assessed using the Behavior Rating Inventory of Executive Function-Adult Version (BRIEF-A) Global Executive Composite (GEC) T-score (standardized score; mean = 50, SD = 10), with higher scores indicating greater executive dysfunction.
Percent weight loss will be calculated as percent change in body weight from baseline to 6 months.
|
Baseline to 6-months
|
|
Moderating effect of emotional eating on percent weight loss at 6 months
Time Frame: Baseline to 6-months
|
Interaction effect between intervention group (SMARTer vs DPP vs Control) and emotional eating on percent weight loss at 6 months, estimated using a linear regression interaction term (β coefficient).
Emotional eating will be assessed using the Palatable Eating Motives Scale (PEMS) Coping subscale mean score (range: 1-5), with higher scores indicating greater eating in response to negative emotions.
Percent weight loss will be calculated as percent change in body weight from baseline to 6 months.
|
Baseline to 6-months
|
|
Mediating effect of change in negative affect on percent weight loss at 6 months
Time Frame: Baseline to 6-months
|
Indirect effect of intervention group (SMARTer vs DPP vs Control) on percent weight loss at 6 months through change in negative affect, estimated using mediation analysis (indirect effect coefficient).
Negative affect will be assessed using the Positive and Negative Affect Schedule (PANAS) Negative Affect subscale score (range: 10-50), with higher scores indicating greater negative affect.
Change will be calculated from baseline to follow-up assessments.
|
Baseline to 6-months
|
|
Mediating effect of change in craving on percent weight loss at 6 months
Time Frame: Baseline to 6-months
|
Indirect effect of intervention group (SMARTer vs DPP vs Control) on percent weight loss at 6 months through change in craving, estimated using mediation analysis (indirect effect coefficient).
Craving will be assessed using a 1-item visual analogue scale (VAS) (range: 0-100), with higher scores indicating greater craving.
Change will be calculated from baseline to follow-up assessments.
|
Baseline to 6-months
|
|
Mediating effect of change in reward-based eating on percent weight loss at 6 months
Time Frame: Baseline to 6-months
|
Indirect effect of intervention group (SMARTer vs DPP vs Control) on percent weight loss at 6 months through change in reward-based eating, estimated using mediation analysis (indirect effect coefficient).
Reward-based eating will be assessed using the Reward-Based Eating Drive (RED) scale total score (continuous; higher scores indicate greater reward-driven eating).
Change will be calculated from baseline to 6 months.
|
Baseline to 6-months
|
|
Mediating effect of change in inhibitory control on percent weight loss at 6 months
Time Frame: Baseline to 6-months
|
Indirect effect of intervention group (SMARTer vs DPP vs Control) on percent weight loss at 6 months through change in inhibitory control, estimated using mediation analysis (indirect effect coefficient).
Inhibitory control will be assessed using the Behavior Rating Inventory of Executive Function-Adult Version (BRIEF-A) Inhibit subscale T-score (mean = 50, SD = 10), with higher scores indicating poorer inhibitory control.
Change will be calculated from baseline to 6 months.
|
Baseline to 6-months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Bonnie Spring, PhD, Florida State University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
June 25, 2024
Primary Completion (Estimated)
April 30, 2027
Study Completion (Estimated)
October 31, 2027
Study Registration Dates
First Submitted
May 8, 2023
First Submitted That Met QC Criteria
May 8, 2023
First Posted (Actual)
May 17, 2023
Study Record Updates
Last Update Posted (Actual)
April 15, 2026
Last Update Submitted That Met QC Criteria
April 10, 2026
Last Verified
April 1, 2026
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- STUDY00005828
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Obesity
-
Dr. Christopher McGowanRecruitingObesity Prevention | Obesity Recidivism | Obesity and Overweight | Obesity and Obesity-related Medical ConditionsUnited States
-
Central Hospital, Nancy, FranceNot yet recruiting
-
Helsinki University Central HospitalKarolinska Institutet; Folkhälsan Researech CenterEnrolling by invitation
-
Istanbul Medipol University HospitalMedipol UniversityCompletedObesity, Morbid | Obesity, Adolescent | Obesity, Abdominal | Weight, Body | Obesity, VisceralTurkey
-
Washington University School of MedicinePatient-Centered Outcomes Research Institute; Pennington Biomedical Research... and other collaboratorsCompletedOvernutrition | Nutrition Disorders | Overweight | Body Weight | Pediatric Obesity | Body Weight Changes | Childhood Obesity | Weight Gain | Adolescent Obesity | Obesity, Childhood | Overweight and Obesity | Overweight or Obesity | Overweight AdolescentsUnited States
-
Queen Fabiola Children's University HospitalNot yet recruitingMorbid Obesity | Adolescent Obesity | Bariatric SurgeryBelgium
-
The Hospital for Sick ChildrenCompleted
-
Ihuoma EneliCompletedObesity, ChildhoodUnited States
-
Dr. Christopher McGowanRecruitingObesity Prevention | Obesity Recidivism | Obesity and Overweight | GLP-1 | Obesity and Obesity-related Medical Conditions | Ablation TechniquesUnited States
-
Azienda Ospedaliero-Universitaria Consorziale Policlinico...Institute of Biomembranes, Bioenergetics and Molecular Biotechnologies; Istituti... and other collaboratorsCompletedMorbid Obesity | Metabolically Healthy ObesityItaly
Clinical Trials on Diabetes Prevention Program (DPP)
-
The University of Texas Medical Branch, GalvestonWithdrawnHypertension | Prediabetic State | Overweight or Obesity | Gestational Weight Gain
-
Johns Hopkins UniversityNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)CompletedPreDiabetes | Type 2 Diabetes | Obesity, Childhood | Overweight and Obesity | Lifestyle, Healthy | Overweight, ChildhoodUnited States
-
University of Kansas Medical CenterKansas State University; National Institute of General Medical Sciences (NIGMS)CompletedWeight Loss | PreDiabetes | Lifestyle Risk ReductionUnited States
-
Indiana UniversityIndiana Clinical and Translational Sciences Institute; Regenstrief Institute... and other collaboratorsCompleted
-
University of Mississippi Medical CenterAmerican Medical Association; Mississippi State Department of HealthActive, not recruitingPreDiabetes | Prediabetic StateUnited States
-
University of California, San FranciscoAmerican Heart AssociationCompletedCardiovascular Diseases | Obesity | Stress, Psychological | Weight Loss | Cardiovascular Risk Factor | Diabetes Prevention | Job Stress | Weight MaintenanceUnited States
-
University of UtahOhio State University; National Tongan American SocietyNot yet recruitingPhysical Inactivity
-
University of California, San FranciscoAmerican Heart AssociationCompletedCardiovascular Diseases | Obesity | Stress, Psychological | Weight Loss | Cardiovascular Risk Factor | Diabetes Prevention | Job Stress | Weight MaintenanceUnited States
-
University of Missouri, Kansas CityChildren's Mercy Hospital Kansas City; University of Massachusetts, Amherst; University... and other collaboratorsRecruitingPreDiabetes | Overweight and ObesityUnited States
-
University of RochesterCompleted